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homocysteine (Hey), with coronary artery disease in Japanese males. The
diagnosis of coronaty artery disease of all the studied patients were con-
firmed by coronaty angiography. The AW polymorphism was analyzed by
PCR followed by f-finfl digestion. The screening of 778 male volunteer con-
trols revealed that the allele frequency of the substitution in Japanese is
0.33, comparable with that in French Canadian population, which have been
reported. The VVgenotype, which correlates with increased plasma Hcy lev-
els due to the reduced activity and increased thermolability of this anzyme,
is significantly more frequent in patients with myocardial infarction (17.3%,
n = 202) than in controls (10.2Yo,n = 778) (P = 0.0048). In mntrast, the
frequency of the IWgenotype in patients with non-occlusive coronary artery
dieease (11.8%,n= 144)was not significantly higherthan that in controls. The
fasting plasma Hcy levels in VVsubjects were higher than those in AVand
AA subjects. We conclude that the VVgenotype of MTHFR associated with
increased plasma Hcy levels may represent an important genetic risk factor
for coronary artery disease, especially with the occurrenw of myocardial
infarction.
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El7701 CardiacTiaaueAngiotenainConvertingEnzyme(ACE)BindingSitaaareIncraasedin HumanHeati
Failure
L.S. Zisman, D.L. Dutcher, M. Jenkin, E.W. Bush, T. Bohlmeyer,
M.R. Bristow, M.B. Perfymen. Univefsifyof Colorado Health Sciencea
Centec Denvec CO, USA
Previous studies have shown that ACE mRNA abundance is increased in
failing compared to nonfailing human heart. However, it is not known if ACE
density is comespondingly increased in cardiac tissue from failing human
hearls. Furthermore, the cellular bcation of ACE production in the human
heart is not known. We used radioligand binding with 3H-ramiprflatto quantify
the density of ACE in eolubilized left ventricular membranes from failing and
nonfailing explanted human hearts, and in situ PCR to localize ACE mRNA
to specific cell types in human left ventricles (LVS). Binding studiee were
performed on 32 failing hearts obtained at the time of cardiac transplantation
from patients with idiopathic dilated cardiomyopathy (lDC) and 24 nonfailing
hearts. ACE Bmax in LV membranes from the IDC hearts was 548 + 40
fmollmg compared to 346 * 30 fmol/mg for the nonfailing hearts (mean +
SEM, p <0.001, unpaired t-test). /nsitu PCRperformed ontieauefrom2 IDC,
2 iachemic, end 4 nonfailing hearts demonstrated ACE mRNA in endothelial
cells and csrdiac myccytes. There was no difference in localization pettern
in failing veraus non-failing hearta.
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Cone/uaions:1)ACE binding sites are increased in failing human heart; 2)
ACE mRNA is localized to endothelial cells and cardiac myocytes in human
heart.
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El7702 Long-TermACEInhibitionAttenueteeCardiocyteApoptoaieinDogsWithModerateHeartFailure
A. Goussev, H.N. Sabbah, V.G. Sharov, H. Shimoyama, M. Lesch,
S. Goldstein. Henry Ford Hear?and Vascular lrrstitute, Detroit, Ml, USA
We previously showed that cardiocyfe apoptosis (programmed cell death)
occurs in dogs with chronic heart failure (HF). We also showed that early,
long-term therapy with the ACE inhibitor enalapril (ENA) attenuates the pro-
gressive loss ofcerdiocyfes in myocardium of HF dogs and presewes overall
LV function. In the present study, reexamined the possibility that the attenu-
ation of the progressive loss of cardiocytea in dogs with HF treated with ENA
may be due, in part, to attenuation of cardiocyte apoptosis. A total of 14 HF
dogs (EF 30%-40%), produced by intracoronary microembolizations, were
randomized to 3 months therapy with ENA (10 mg Bid, n = 7)’orto no therapy
at all (CONTROL, n = 7). At the end of 3 months of therapy, dogs were sac-
rificed and the hearts removed. The presence of nuclear DNA fragmentation
(DNAf), a marker of apoptosis, was assessed in frozen LVsections using the
Oncor ApepTagfluorescein kit. Sections were double stained with ventricular
antimyosin antibody to identify cells of cardiccyfe origin. A total of 20 fields
(magnification x40) were examined from sections obtained from each dog.
Among cells of cerdiocyte origin, the number of nuclear DNAf eventa was
significantly lower in Entreated dogs compared to CONTROL (0.084Z0.06
vs. 0.39 + 0.12 DNAf eventa/fieid) (p= 0.039). Conclusions: Early, long-term
therapy with ENA attenuates cardiocyte apoptosis in dogs with mcderate
HF.Attenuation of cardiocyte death by apoptosis may be one mechanism by
which ENA attenuates the ongoing loss of viable cardiocytes and presewes
overall LV function of the failing LV.
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m7703 NorapinephrineDirectlyInduceaApoptoaiainNeonatalRatMyocytea
T. Matsui, R.J, Hajjar, J.X. Kang, A. Rosenzweig. Cardiovascular Research
Centec Massechusei?s,USA, General Hospital, Chsrfestown, MA, USA
Congestive heart failure (CHF) is accompanied by elevated levels of cete-
cholamines which are known to produce cardiac toxicity but the underlying
mechanism has not been elucidated. Apoptosis has been documented re-
cently in animal models of heart failure and in patients with dilated cardiomy-
opathy. To test the hypothesis that catecholamines directly induce cardiocyte
S@OPtOSiS, We exposed nSOnatSlrat myocytes to norepinephrine (NE) (0.1
KM, 1 #M, or 10 KM for96 hra). We evaluated cultured cells forapoptoais by
1) nucleosome Iaddering (DNA electrophoresis), 2) Hoechst staining for nu-
clear morphology, 3) terminal deoxynucleotidyl transferase mediated dUTP
nick end labeling (TUNEL), 4) Flow cytometry (FACS), and 5) Poly ADP-
Ribese Polymeraee (PARP) fragmentation (Western blotting). Results of all
aaaays were consistent with FACS which provided the most precise quan-
titation of apoptoais. Although basal cardiocyte culturea exhibit a low level
of apoptosis (0.42% by FACS), NE stimulation induced significantly greater
apeptosis in a dose-dependent manner (33.97% at 10 KM by FACS). TUNEL
assay and DNA electrophoresis were diagnostic of apoptotic cell death after
NE treatment. Western blotting, using the anti-PARP monoclinal antibody
demonstrated PARP cleavage consistent with ICE-family proteases. Addi-
tion of prezosin (1 wM) or propranolol (1 wM) to NE-stimulated cardiocyle
cultures partially reducad the degree of apoptosis (19.44% at 0.1 KM NE
to 10.33% with prezosin or 14.86% with propranolol). We conclude that (1)
NE directly induces apoptosis in cultured cerdiocytes; (2) this effect is in-
completely blocked by a- or &antagonists; and (3) PARP is cleaved in these
cultures, suggesting ICE-family activation. These findings point to apopto-
sis as a mechanism of adrenergic-mediated myocardial injury and may be
relevant to in vivo hyperadrenergic statas such as CHF.
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[770-4]MicrotubuleAaaemb,YAfiecta@-adrener9ic
MediatedContractilityin HumanIechemicDilated
Cardiomyopathy
R.D. Bies, M. Maeda, E. Holder, S. Valent, R. Roden, W. Abraham,
M. Bristow. Division of Cardio/og~ VAMedical Center and University of
Colorado Health Sciences CenteL Denvec CO, USA
Microtubules (MT) are believed to have a role in modulating contractility and
G protein coupling to adenylyl cyclase in animal models of cardiac myocyte
function. We therefore analyzed the integrity and physiological significance of
microtubule asaembly/disaaaembly in human cardiac tissues. MT separation
from the soluble free tubulin cell fraction was performed on four freshly ex-
planted non-failing human hearts intended fortransplantation, and ten freshly
explanted failing hearts from subjects with ischemic dilated cardiomyopathy
(Isch). Scanning densitometry of Western blots showed a loss of MT in Isch
heatta and a - 65% increase in the ratio of free tubulin verses MT tubulin
(free/MT = 1.14) compared to normal controls (free/MT= 0.69). In tissue bath
experiment, 100 fresh RV trabeculae from 9 Iach hearta were exposed to a
4 hour incubation with 10 KM taxol (TAX) or 10 PM colchicine (COL) to either
increase or disrupt microtubules, respectively,and were compared to vehicle
controls (CON). Isoproterenol (10-9M to 10-4M) stimulated maximal tension
response (mg; stimulated minus basal) was measured and exhibited a 30Y0
increase in peak systolic tension with TAX (1620 mg) compared to CON
(1368 mg) or COL (1455 mg), (p= 0.02). Tension response to direct stimu-
lation with Ca2+ (5 mM and 10 mM) revealed no difference between groupa
(p= 0.7); CON (1401 mg), TAX (1491 mg), COL (1427 mg). These results
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suggest that microtubules are disrupted in human ischemic cardiomyopathy,
and that this abnormality may contribute to uncoupling of p-receptor signal
transduction. An increase in MT with TAX appeara to partially correct this
defect, and partially restore b-adrenergic responsiveness to failing human
Iachemic myooardium.
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770-5 TNF-a Decreeeee @Adrenergic Effects on Humeri
Ventricle
J.J. Komitau, B.R. Stephany, R.W. Stewart, C.S. Moravec. The Cleveland
Clinic Foundation, Cleveland, OH, USA
Studies have shown that serum levels of tumor necrosis factor alpha (TNF-
LY)are increased in patients with heart failure. Because of the possibility
that elevated levels of this cytokine could contribute to cardiac dysfunction,
the inotropic effects of TNF-IYhave been studied in several animal models,
where it haa been ahown to have a direct negative inotropic effect and to
decrease the effects of p-adrenergic stimulation. To date, however, it has
not been established whether similar effects exist in the human heart. We
have examined the direct effects of TNF-a on human cardiac muscle. Using
paired ventricular trabecular muscles obtainad from the hearts of cardiac
transplant recipients, one muscle was exposed to a single dose (200 U/ml)
of TNF-a end the second muacle served as a time control. After 40 min.,
10-6 M isoproterenol was added to both baths. Contractile parameters were
measured at b (before the addition of TNF-a), 40 minutes after addition
of TNFw to one bath, and 5 minutes after addition of isoproterenol to both
baths. Data indicate that, unlike what has been shown in animal models,
TNFw does not have a aignificent effect on baseline contractility (TNF-a
decreased isometric tension by 1.5 +3.7%; time alone ceusedadecrease of
1.0 + 8.8Yo). However, when muscles were incubated with 200 U/ml TNF-a
prior to isoproterenol treatment, the change in isometric tension in response
to isoproterenol wassignificently diminished from 164.9 *29.7% (lSOalone)
to 72.2+ 11.3% (TNF-o + ISO; p z 0.01). These data suggest that elevated
serum TNF-a may contribute to the decreased B-adrenergic response seen
in heart failure patients.
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Decreaaed type VI but not type V Adanylyl Cyclaee
—. . . —
mRNA Iaoform Expreeeion in the Left Ventricle of
Rata With Myocardial Infarction and Heart Failure
1.Eapinasse, V. Iourgenko, C. Richer, M. Heimburger, N. Defer, E. Puseard,
J.-F. Giudicelli, J.-B. Michel, J.-J. Mercedier. Univeraire de Paris X/, CNRS
URA 1159,Le Plessk Robinson, France
To determine if the decreased myocerdial production of cAMP during heart
failure maybe due, at least in part, to reduced expression of adenylyl cyclaae
(AC) genes, we measured AC activity and the mRNA concentrations of
the two main (types V and Vl) cardiac AC isoforms in the left ventrtcle
(LV) of control rats (C) and in the non-infarcted area of the LV of rats
with myocardial infar~ion (Ml), with (F) or without (H) LV failure. Ml was
induced by ligation of the left coronary artery and rats were studied 6 montha
thereafter. The presence of LV failure was asaeeeed on a right ventricular
weight to body weight ratioand a urinary cGMP excretion more than twice the
mntrol values. Basal (B) and forskolin-stimulated (Fsk) AC activities were
determined according to standard procedures. AC mRNA concentrations
were assessed by Northern blot analysis and RNase protection assay (RPA)
with isoformspecific ACcDNAs, relative to GAPDH, poly-(A+) and 18S RNAs.
In rats with Ml, B and Fsk AC activities were decreased by approximately
60% only in F rats compared to C (p <0.05 for the 2 comparisons). In the
3 rat groups, LV type V AC mRNA concentration was 4 to 6 times that of
type V1.No difference in LV type V AC mRNA concentration was obsewed
between the 3 rat groups, whether this mRNA was normalized to GAPDH,
poly-(A+) or 18S RNAs. In contrast, a 35% decrease in the type VI mRNA
to poly-(A+) RNA ratio was observed only in F rats compared to C (0.85 +
0.05 vs 1.01 + 0.09, p < 0.05). Conclusion: heart failure reaulting from Ml in
rats is not associated with altered expression of the most abundant, type V,
ventricular AC mRNA isoform. In contrast, decreased AC activity in failing LV
may be related, at least in part, to decreased type VI AC gene expression.
